Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
暂无分享,去创建一个
T. Luedde | M. Manns | M. Ott | F. Tacke | P. Schirmacher | L. Zender | S. Kubicka | M. Heikenwalder | D. Bruder | S. Weiss | T. Longerich | M. Vucur | J. Gil | T. Kang | T. Yevsa | N. Woller | M. Iken | A. Potapova | M. Gereke | T. Wuestefeld | D. Dauch | Sadaf Khan | L. Hoenicke | Anja Hohmeyer | Ramona Rudalska | Anna Potapova
[1] J. Rockstroh,et al. HIV and cancer in Germany. , 2011, Deutsches Arzteblatt international.
[2] S. Lowe,et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas , 2011, Nature.
[3] Thomas J. Fuchs,et al. TAK1 suppresses a NEMO-dependent but NF-kappaB-independent pathway to liver cancer. , 2010, Cancer cell.
[4] Manuel T. Silva. When two is better than one: macrophages and neutrophils work in concert in innate immunity as complementary and cooperative partners of a myeloid phagocyte system , 2010, Journal of leukocyte biology.
[5] Deborah M. Brown,et al. Cytolytic CD4 cells: Direct mediators in infectious disease and malignancy. , 2010, Cellular immunology.
[6] D. Peeper,et al. Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network , 2008, Cell.
[7] Jonathan Melamed,et al. Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence , 2008, Cell.
[8] T. Böhler,et al. Reconstitution of immunodeficient SCID/beige mice with human cells: applications in preclinical studies. , 2008, Toxicology.
[9] M. Frid,et al. Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage. , 2006, The American journal of pathology.
[10] Corey M. Carlson,et al. Somatic integration of an oncogene-harboring Sleeping Beauty transposon models liver tumor development in the mouse. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[11] S. Lowe,et al. Senescence comes of age , 2005, Nature Medicine.
[12] M. Taketo,et al. Hepatocarcinogenesis in Mice with β-Catenin and Ha-Ras Gene Mutations , 2004, Cancer Research.
[13] T. Jacks,et al. Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry , 2003, Nature.
[14] R. Bernards,et al. Reversal of Senescence in Mouse Fibroblasts through Lentiviral Suppression of p53* 210 , 2003, The Journal of Biological Chemistry.
[15] B. Pearce. Models and Mechanisms , 2003 .
[16] M. Vasseur-Cognet,et al. A tamoxifen‐inducible chimeric Cre recombinase specifically effective in the fetal and adult mouse liver , 2002, Hepatology.
[17] T. Jacks,et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. , 2001, Genes & development.
[18] J. Campisi,et al. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[19] Richard A. Ashmun,et al. Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19 ARF , 1997, Cell.
[20] Asim Khwaja,et al. Matrix adhesion and Ras transformation both activate a phosphoinositide 3‐OH kinase and protein kinase B/Akt cellular survival pathway , 1997, The EMBO journal.
[21] D. M. Carlson,et al. Gene expression following direct injection of DNA into liver. , 1994, Human gene therapy.
[22] W. Uttal. On models and mechanisms , 1992, Behavioral and Brain Sciences.
[23] P. M. Rao,et al. Liver tumour promotion by chemicals: models and mechanisms. , 1986, Cancer surveys.